Ion Beam Applications
IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off. It employs about 1500 people in 40 locations.[1] The company is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation.[2]
 Headquarters of Ion Beam Applications (IBA) in Louvain-la-Neuve | |
| Public | |
| Traded as | Euronext: IBAB |
| Industry | Medical technology |
| Founded | 1986 |
| Founder | Yves Jongen |
| Headquarters | , |
Area served | Worldwide |
Key people | Olivier Legrain (CEO) |
| Website | iba-worldwide |
IBA installed proton therapy equipment for Boston's Massachusetts General Hospital in 2001, and for Philadelphia's Penn Hospital in 2009.[3]
It is supplying equipment and services to Proton Partners International which is developing three proton beam therapy centres in the United Kingdom.[4][5]
References
- "IBA SA - basic data - update following capital increase dated 15 December 2016". Yahoo Finance. 15 December 2016. Retrieved 24 December 2016.
- "Ion Beam Applications: IBA". Healthcare Belgium. Retrieved 24 December 2016.
- Langreth, David Whelan and Robert (2009-02-26). "The $150 Million Zapper". Forbes. Retrieved 2017-07-30.
- "BRIEF-Ion Beam Applications signs two contracts with Proton Partners International". Reuters. 13 December 2016. Retrieved 24 December 2016.
- "Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment". News medical. 9 December 2016. Retrieved 24 December 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.